Corporate Author

International Agency for Research on Cancer

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

Place of Publication

Lyon, France

Publisher

International Agency for Research on Cancer

Publication Date

2015

Physical Description

xii, 422 p. : ill.

Series

IARC monographs on the evaluation of carcinogenic risks to humans 108

Subjects

Carcinogens - pharmacology

Drug-Related Side Effects and Adverse Reactions

Plant Preparations - adverse effects

Pharmaceutical Preparations - adverse effects

Plants, Medicinal - adverse effects

Cell Transformation, Neoplastic - drug effects

Abstract

This publication represents the views and expert

opinions of an IARC Working Group on the

Evaluation of Carcinogenic Risks to Humans,

which met in Lyon, June 2013.

Notes

Monographs:

Aloe vera

Goldenseal

Ginkgo biloba

Kava

Pulegone

Methylene blue

Primidone

Sulfasaazine

Pentosan polysulfate sodium

Triamterene

Hydrochlorothiazide

Pioglitazone and rosiglitazone

Digoxin

ISBN

9789283201748

ISSN

1017-1606

Language

English

French

Material Type

Book

Online

Audience

Professional

Location

Internet

Website Notes

PDF format and supplementary material

Alternate Title

Ecoutez mon histoire

Corporate Author

Northeastern Ontario Regional Cancer Centre

Place of Publication

Sudbury, Ont.

Publisher

BBS, MCTV

Publication Date

1996

Physical Description

25 minutes ; 1 booklet

Subjects

Neoplasms - psychology

Parent-Child Relations

Adolescent Psychology

Popular Work

Language

English

French

Material Type

Video

DVD

Audience

Patient or Public

Location

Vancouver Library

Call Number

QZ201 H435 1996

Copies

Alternate Title

Canadian strategy for cancer control

Canadian strategy for cancer control 2019-2029 : doing together what cannot be done alone

Corporate Author

Canadian Partnership Against Cancer

Place of Publication

[Toronto, ON]

Publisher

Canadian Partnership Against Cancer

Publication Date

[2019]

Subjects

Neoplasms - prevention & control

Health Planning

Delivery of Health Care

Health Services, Indigenous

Research

Canada

Abstract

Strategy's priorities:

Priority 1 - Decrease the risk of people getting cancer.

Priority 2 - Diagnose cancer faster, accurately and at an earlier stage.

Priority 3 - Deliver high-quality care in a sustainable, world-class system.

Priority 4 - Eliminate barriers to people getting the care they need.

Priority 5 - Deliver information and supports for people living with cancer, families and caregivers.

First Nations, Inuit and Métis - 3 key cancer-care priorities:

Priority 1 - Culturally appropriate care closer to home

Priority 2 - Peoples-specific, self-determined cancer care

Priority 3 - First Nations-, Inuit- or Métis-governed research and data systems

ISBN

9781988000398

9781988000381

Language

English

French

Material Type

Report

Online

Audience

Professional

Location

Internet